Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure

Epidemiology

Volumn 14, Issue 2, 2003, Pages 240-246

  García Rodríguez, Luis Alberto ^a   Hernández Díaz, Sonia ^b  

^a Department of Pharmacoepidemiology   (Spain)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Acetaminophen; Epidemiologic studies; Heart failure; Nonsteroidal antiinflammatory drugs

Indexed keywords

ACECLOFENAC; ACEMETACIN; AZAPROPAZONE; COCODAMOL; CODYDRAMOL; DEXTROPROPOXYPHENE; DICLOFENAC; ETODOLAC; FENBUFEN; FENOPROFEN; FLURBIPROFEN; INDOMETACIN; KETOPROFEN; MEFENAMIC ACID; MELOXICAM; METOCLOPRAMIDE; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; SULINDAC; TENOXICAM; TIAPROFENIC ACID;

ADULT; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE PREDISPOSITION; EVALUATION; FEMALE; GENERAL PRACTITIONER; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED KINGDOM; AGED; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; GREAT BRITAIN; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0037946702     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-200303000-00020     Document Type: Article

References (27)

1. García Rodríguez LA, Varas-Lorenzo C, Patrono C. Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women. Epidemiology 2000;11:383-387.
2. Ray W, Stein C, Hall K, Daugherty J, Griffin M. Non-steroidal anti-inflammatory drugs and the risk of serious coronary heart disease. Lancet 2002;359:118-123.
3. Velentgas P, Cali C, Dreyer N, Verburg KM, Walker A. Risk of myocardial infarction and cardiac death among users of non-steroidal anti-inflammatory medications. Pharmacoepidemiol Drug Saf 2001;10(suppl 1).
4. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:308:81-106.
5. Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998;158:1108-1112.
6. Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an unrecognized public health problem. Arch Intern Med 2000;160:777-784.
7. Johnson A. NSAIDs and increased blood pressure. What is the clinical significance? Drug Saf 1997;17:277-289.
8. Johansson S, Wallander MA, Ruigómez A, García Rodríguez L. Incidence of newly diagnosed heart failure in general practice. Eur J Heart Fail 2001;3:225-231.
9. García Rodríguez LA, Pérez Gutthann S. Use of the UK general practice research database for pharmacoepidemiology. Br J Clin Pharmacol 1998;45:419-425.
10. Jick H, Jick S, Dervy L. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-768.
11. Jick H, Terris B, Derby L, Jick S. Further validation of information recorded on a general practitioner based computerised data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992;1:347-349.
12. García Rodríguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:769-772.
13. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman-Gilman A. Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1996.
14. Mene P, Pugliese F, Patrono C. The effect of nonsteroidal anti-inflammatory drugs on human hypertensive vascular disease. Semin Nephrol 1995;15:244-252.
15. Ruoff GE. The impact of nonsteroidal anti-inflammatory drugs on hypertension: alternative analgesics for patients at risk. Clin Ther 1998;20:376-387.
16. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999;106:13S-24S.
17. Pérez-Gutthann S, García Rodríguez LA, Raiford DS, Duque Oliart A, Romeu JR. Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med 1996;156:2433-2439.
18. Griffin M, Yared A, Ray W. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 2000;151:488-496.
19. Beard K, Lawson D, MacFarlane G. Non-steroidal anti-inflammatory drugs and acute renal disease: a case-control study. Pharmacoepidemiol Drug Saf 1992;1:3-9.
20. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 1994;331:1675-1678.
21. Evans J, McGregor E, McMahon A, et al. Nonsteroidal antiinflammatory drugs and hospitalization for acute renal failure. Q J Med 1995;88:551-557.
22. Henry D, Page J, Whyte I, Nanra R, Hall C. Consumption of nonsteroidal antiinflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case-control study. Br J Clin Pharmacol 1997;44:85-90.
23. Whelton A, Stout RL, Spilman PS, Klassen DK. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. Ann Intern Med 1990;112:568-576.
24. Hall D, Holger Zeitler H, Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol 1992;20:1549-1555.
25. Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal antiinflammatory drugs. Am J Med 1998;104:413-421.
26. Warner T, Giuliano F, Vojnovic I, Bukasa A, Mitchell J, Vane J. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity; a full in vitro analysis. Proc Natl Acad Sci USA 1999;96:7563-7568.
27. Ulcickas YM, Rothman K, Johnson C, et al. Using prescription claims for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf 2000;9:S37.